Söndag 22 December | 02:13:13 Europe / Stockholm
Svenska | English

Bio-Works Technologies

Bifogade filer

Kursutveckling under dagen för detta pressmeddelande (SEK).

Prenumeration

Kalender

Tid*
2025-02-21 08:30 Bokslutskommuniké 2024
2024-08-02 - Kvartalsrapport 2024-Q2
2024-07-29 - Extra Bolagsstämma 2024
2024-05-27 - X-dag ordinarie utdelning BIOWKS 0.00 SEK
2024-05-24 - Årsstämma
2024-02-19 - Bokslutskommuniké 2023
2023-08-18 - Kvartalsrapport 2023-Q2
2023-05-29 - X-dag ordinarie utdelning BIOWKS 0.00 SEK
2023-05-26 - Årsstämma
2023-02-17 - Bokslutskommuniké 2022
2022-08-19 - Kvartalsrapport 2022-Q2
2022-05-23 - X-dag ordinarie utdelning BIOWKS 0.00 SEK
2022-05-20 - Årsstämma
2022-05-06 - X-dag ordinarie utdelning BIOWKS 0.00 SEK
2022-02-18 - Bokslutskommuniké 2021
2021-11-25 - Extra Bolagsstämma 2021
2021-08-20 - Kvartalsrapport 2021-Q2
2021-05-24 - X-dag ordinarie utdelning BIOWKS 0.00 SEK
2021-05-21 - Årsstämma
2021-02-19 - Bokslutskommuniké 2020
2020-08-21 - Kvartalsrapport 2020-Q2
2020-05-18 - X-dag ordinarie utdelning BIOWKS 0.00 SEK
2020-05-15 - Årsstämma
2020-02-14 - Bokslutskommuniké 2019
2019-10-18 - Kvartalsrapport 2019-Q3
2019-08-23 - Kvartalsrapport 2019-Q2
2019-05-27 - X-dag ordinarie utdelning BIOWKS 0.00 SEK
2019-05-17 - Årsstämma
2019-04-29 - Kvartalsrapport 2019-Q1
2019-02-22 - Bokslutskommuniké 2018
2018-08-19 - Kvartalsrapport 2018-Q2
2018-05-21 - X-dag ordinarie utdelning BIOWKS 0.00 SEK
2018-05-18 - Årsstämma
2018-02-19 - Bokslutskommuniké 2017

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriBioteknik
Bio-Works Technologies är verksamt inom bioteknik. Bolaget utvecklar produkter som separerar och renar molekyler vid framställning av läkemedel. Teknologin baseras på kromatografi som har som avsikt att hantera läkemedelssubstansen. Kunderna återfinns inom den europeiska marknaden där produkterna säljs via distributionspartners och till bolag inom läkemedelsindustrin, samt forskningsinstitut och universitet. Bolaget bildades 2006 och har sitt huvudkontor i Uppsala.
Bio-Works comfirms an order from Nemysis Ltd worth 2.2 MSEK
2024-11-04 16:30:00

Bio-Works confirmed a new order of WorkBeads NiMAC, to Nemysis Ltd, an Irish developer of bioactive substances designed to target nutritional disorders and deficiencies. The order, worth approximately 2.2 MSEK, will enable Nemysis to scale-up one of its programs to minimize gastrointestinal disorders.

"Bio-Works is very pleased to be able to support Nemysis in its mission to create products which prevent the negative side effects of nutrient disorders and deficiency," said Lone Carlbom, CEO of Bio-Works Technologies. “This order is evidence that our strategy to create unique purification products is in line with the needs of a diversifying platform of biotherapeutic molecules.”

“Bio-Works provided us with an excellent affinity resin and related support to optimize the purification of our enzyme and speed up the downstream operations. Nemysis strongly believes the collaboration with Bio-Works will continue as a strategic relationship in its production of the best quality of this valuable finished product.” said Cristina Comelli, CSO at Nemysis Ltd.

Nemysis Ltd. is a Specialty Pharmaceutical Company focused on therapeutic solutions for highly prevalent nutritional disorders and deficiencies, delivering products to the healthcare market.

Contacts:
For more information, please visit the Bio-Works homepage at, www.bio-works.com or contact: Lone Carlbom, CEO, e-mail: lone.carlbom@bio-works.com, phone: +46(0)8-502 705 84.

About Bio-Works
Bio-Works enables Biotech companies to achieve their goals for purification of biomolecules. We support our customers, from laboratory research to commercial production, and together we implement efficient and robust solutions for bioprocessing. Our ambition is to be a trusted and dynamic partner in an industry characterized by growth and development.

Bio-Works’ headquarters, with R&D and manufacturing, is located in Uppsala Business Park in Uppsala, Sweden. We supply products globally, through a combination of direct sales and via distributors in Europe, North America and Asia. The company is certified according to the ISO 9001:2015 quality management system. Bio-Works is listed on Spotlight Stock Market ("BIOWKS"). For more information, visit www.bio-works.com.

Attachments
Bio-Works comfirms an order from Nemysis Ltd worth 2.2 MSEK

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden